These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 35911346)
1. Impact of the Drug Prices Control Order (2013) on the Utilization of Anticancer Medicines in India: An Interrupted Time-Series Analysis. Sharma B; Mehta A; Farooqui HH; Negandhi H; Selvaraj S Cureus; 2022 Jun; 14(6):e26367. PubMed ID: 35911346 [TBL] [Abstract][Full Text] [Related]
2. Evaluating the impact of price regulation (Drug Price Control Order 2013) on antibiotic sales in India: a quasi-experimental analysis, 2008-2018. Selvaraj S; Farooqui HH; Mehta A; Mathur MR J Pharm Policy Pract; 2022 Oct; 15(1):68. PubMed ID: 36273222 [TBL] [Abstract][Full Text] [Related]
3. New Evidence of the Impact of the National Drug Price Negotiation Policy on the Availability, Utilization, and Cost of Anticancer Medicines in China: An Interrupted Time Series Study. Gao X; Yu M; Sun Y; Zhang T; Li X; Zhang L; Wang C Risk Manag Healthc Policy; 2024; 17():2201-2208. PubMed ID: 39309121 [TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies. Acosta A; Ciapponi A; Aaserud M; Vietto V; Austvoll-Dahlgren A; Kösters JP; Vacca C; Machado M; Diaz Ayala DH; Oxman AD Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005979. PubMed ID: 25318966 [TBL] [Abstract][Full Text] [Related]
5. The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis. Rong X; Yin J; Duan S; Sun Q; Babar ZU BMC Public Health; 2020 Apr; 20(1):588. PubMed ID: 32349722 [TBL] [Abstract][Full Text] [Related]
6. Impact of the national drug price negotiation policy on the utilization, cost, and accessibility of anticancer medicines in China: A controlled interrupted time series study. Cai L; Tao T; Li H; Zhang Z; Zhang L; Li X J Glob Health; 2022 Dec; 12():11016. PubMed ID: 36527382 [TBL] [Abstract][Full Text] [Related]
7. Does price regulation affect atorvastatin sales in India? An impact assessment through interrupted time series analysis. Selvaraj S; Farooqui HH; Mehta A BMJ Open; 2019 Jan; 9(1):e024200. PubMed ID: 30679294 [TBL] [Abstract][Full Text] [Related]
8. Evaluating the impact of the single exit price policy on a basket of originator medicines in South Africa from 1999 to 2014 using a time series analysis. Moodley R; Suleman F BMC Health Serv Res; 2019 Aug; 19(1):576. PubMed ID: 31419977 [TBL] [Abstract][Full Text] [Related]
9. The impact of the single exit price policy on a basket of generic medicines in South Africa, using a time series analysis from 1999 to 2014. Moodley R; Suleman F PLoS One; 2019; 14(7):e0219690. PubMed ID: 31365534 [TBL] [Abstract][Full Text] [Related]
10. Prices & availability of common medicines at six sites in India using a standard methodology. Kotwani A; Ewen M; Dey D; Iyer S; Lakshmi PK; Patel A; Raman K; Singhal GL; Thawani V; Tripathi S; Laing R Indian J Med Res; 2007 May; 125(5):645-54. PubMed ID: 17642500 [TBL] [Abstract][Full Text] [Related]
11. Impact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analyses. Leopold C; Zhang F; Mantel-Teeuwisse AK; Vogler S; Valkova S; Ross-Degnan D; Wagner AK Int J Equity Health; 2014 Jul; 13():53. PubMed ID: 25062657 [TBL] [Abstract][Full Text] [Related]
12. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020. Yıldız M; Osman E Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516 [TBL] [Abstract][Full Text] [Related]
13. Impact of National Drug Pricing Policy 2018 on access to medicines in Lahore division, Pakistan: a pre-post survey study using WHO/HAI methodology. Saeed A; Saeed H; Saleem Z; Yang C; Jiang M; Zhao M; Ji W; Aziz MM; Khan FU; Gillani AH; Atif N; Fang Y; Babar ZUD BMJ Open; 2020 Oct; 10(10):e034720. PubMed ID: 33033079 [TBL] [Abstract][Full Text] [Related]
14. Impact of medical insurance access negotiation on the utilization of innovative anticancer drugs in China: an interrupted time series analysis. Li C; Zhu J; Shan L; Zhou Y; Liu G; Zhu H; Wu Q; Cui Y; Kang Z BMC Health Serv Res; 2024 Jan; 24(1):90. PubMed ID: 38233857 [TBL] [Abstract][Full Text] [Related]
15. Does price deregulation increase drug price in China? An interrupted time series analysis. Xiong Y; Xu J; Gao Y Int J Health Plann Manage; 2021 Sep; 36(5):1653-1665. PubMed ID: 34028086 [TBL] [Abstract][Full Text] [Related]
16. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy. Wong SL; Ibrahim S; Abdul Kadir N; Mohd Salleh S Appl Health Econ Health Policy; 2019 Oct; 17(5):641-654. PubMed ID: 31093937 [TBL] [Abstract][Full Text] [Related]
17. Time trends and regional variations in prices of anticancer medicines in China. Zhang J; Hu S; Liu X; Liu X; Zhang J; Yang C; Fang Y Front Pharmacol; 2024; 15():1397784. PubMed ID: 38813105 [TBL] [Abstract][Full Text] [Related]
18. Does India need a new pharmaceutical policy? Examining the implications of the drug price control order. Kumar R; Joshi MM; Palod RJ; Dharmagadda S Int J Health Plann Manage; 2022 Nov; 37(6):3028-3038. PubMed ID: 35983617 [TBL] [Abstract][Full Text] [Related]
19. Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis. Huang C; Ung COL; Wushouer H; Bai L; Li X; Guan X; Shi L Int J Health Policy Manag; 2022 Aug; 11(8):1489-1495. PubMed ID: 34273922 [TBL] [Abstract][Full Text] [Related]
20. Effects of transparent online open procurement on prices, volumes, and costs of medicines: an interrupted time series study in Ningxia, China. Gao J; Liu C; Li Y; Chen X; Xue T; Tang Y Front Pharmacol; 2024; 15():1362374. PubMed ID: 39228526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]